10-87660014-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001015880.2(PAPSS2):c.27+6C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001015880.2 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAPSS2 | NM_001015880.2 | c.27+6C>T | splice_region_variant, intron_variant | ENST00000456849.2 | NP_001015880.1 | |||
PAPSS2 | NM_004670.4 | c.27+6C>T | splice_region_variant, intron_variant | NP_004661.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAPSS2 | ENST00000456849.2 | c.27+6C>T | splice_region_variant, intron_variant | 1 | NM_001015880.2 | ENSP00000406157.1 | ||||
PAPSS2 | ENST00000361175.8 | c.27+6C>T | splice_region_variant, intron_variant | 1 | ENSP00000354436.4 | |||||
ENSG00000196566 | ENST00000354527.2 | n.-11G>A | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000415 AC: 1AN: 240692Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 131784
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1459920Hom.: 0 Cov.: 32 AF XY: 0.00000689 AC XY: 5AN XY: 726196
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74340
ClinVar
Submissions by phenotype
Spondyloepimetaphyseal dysplasia, PAPSS2 type Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 23, 2020 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with PAPSS2-related conditions. This variant is present in population databases (rs761222153, ExAC 0.004%). This sequence change falls in intron 1 of the PAPSS2 gene. It does not directly change the encoded amino acid sequence of the PAPSS2 protein, but it affects a nucleotide within the consensus splice site of the intron. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at